Manufacturer record
Kaalimga Healthcare 1st Floor: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Kaalimga Healthcare 1st Floor (Himachal Pradesh) was declared Not of Standard Quality in July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 25KHT-0857, Calcium citarate malate, Vitamain k2 -7, Vitamin D3, methylcobalamin Zinc and Magnesium Tablets (exp Jul 2027). RDTL. Bellary Karnataka (state lab) found it not of standard quality: test for Disintegration and label claim woth respect to the Identification and Assay for Vitamin D3. Listed in the July 2026 alert.
Records by type
1 record linked to Kaalimga Healthcare 1st Floor in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Calcium citarate malate, Vitamain k2 -7, Vitamin D3, methylcobalamin Zinc and Magnesium Tablets | Batch 25KHT-0857Mfg Aug 2025 · Exp Jul 2027 | test for Disintegration and label claim woth respect to the Identification and Assay for Vitamin D3Assay | RDTL. Bellary KarnatakaState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.